These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The use of several drugs and their risks in pregnancy]. Vázquez-Benítez E Gac Med Mex; 1996; 132(5):541-3. PubMed ID: 9011519 [No Abstract] [Full Text] [Related]
5. [Adverse effects of drugs used in gynecology and obstetrics]. Cesk Gynekol; 1981 Dec; 46(10):791-812. PubMed ID: 7332951 [No Abstract] [Full Text] [Related]
6. Drugs used in pregnancy: the regulatory process. Tomalin A Can J Clin Pharmacol; 2007; 14(1):e5-9. PubMed ID: 17213510 [No Abstract] [Full Text] [Related]
7. [Drugs in pregnancy and lactation]. Lauritzen C Zentralbl Gynakol; 1986; 108(3):137-54. PubMed ID: 3962526 [TBL] [Abstract][Full Text] [Related]
8. [Drug use in pregnancy in Zagreb]. Drazancić A Lijec Vjesn; 2008; 130(1-2):43-4; author reply 45. PubMed ID: 18589644 [No Abstract] [Full Text] [Related]
9. Drugs in pregnancy: acknowledging challenges--finding solutions. Koren G; MacLeod S; Davis D Can J Clin Pharmacol; 2007; 14(1):e2-4. PubMed ID: 17213506 [No Abstract] [Full Text] [Related]
10. [Which drugs are allowed, which should one avoid, which are contraindicated?]. Stahlmann R; Neubert D Gynakologe; 1987 Jun; 20(2):129-36. PubMed ID: 2887491 [No Abstract] [Full Text] [Related]
11. Pregnancy and pills. Rochman B Time; 2009 Jun; 173(22):51-3. PubMed ID: 19522199 [No Abstract] [Full Text] [Related]
12. [Fetal and neonatal adverse effects of maternal drug therapy in the puerperal state. I. Pregnancy at term and labor]. Colla G; Massobrio M Minerva Ginecol; 1967 Oct; 19(19):946-56. PubMed ID: 5606434 [No Abstract] [Full Text] [Related]
13. Challenges in drug use near term and during delivery. Farine D Can J Clin Pharmacol; 2007; 14(1):e29-33. PubMed ID: 17213507 [No Abstract] [Full Text] [Related]
14. Collection and analysis of drug safety data in pregnancy. Moretti M Can J Clin Pharmacol; 2007; 14(1):e34-6. PubMed ID: 17213508 [No Abstract] [Full Text] [Related]
16. [Personal experience with monitoring drug prescriptions in pregnancy]. Barnetová L; Martínková J; Stránská V; Nováková A; Faltová V; Malecková M; Odrázková E; Grätz R; Fajmanová M; Martínková J Cesk Gynekol; 1989 Sep; 54(8):561-74. PubMed ID: 2582500 [TBL] [Abstract][Full Text] [Related]
17. Designing pregnancy centered medications: drugs which do not cross the human placenta. Gedeon C; Koren G Placenta; 2006 Aug; 27(8):861-8. PubMed ID: 16313957 [TBL] [Abstract][Full Text] [Related]
18. 45 years later...where do we stand? Benegbi M Can J Clin Pharmacol; 2007; 14(1):e37-9. PubMed ID: 17213509 [No Abstract] [Full Text] [Related]
19. Inactive pharmaceutical ingredients : implications for pregnancy. Finkelstein Y; Rezvani M; Garcia-Bournissen F; Nurmohamed L; Koren G Can J Clin Pharmacol; 2007; 14(1):e17-28. PubMed ID: 17213505 [No Abstract] [Full Text] [Related]
20. Pregnancy exposure registries: academic opportunities and industry responsibility. Wyszynski DF Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):93-101. PubMed ID: 19107953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]